ZEVIANI, MASSIMO

Rete di Collaborazioni Statistiche Email Alert RSS Feed

Pubblicazioni

Risultati 1 - 20 di 73 (tempo di esecuzione: 0.001 secondi).

	Titolo	Data di pubblicazione	Autori	Rivista
1	Mitochondrial encephalomyopathies	1989	DiMauro, S; ZEVIANI, MASSIMO ; Moraes, C T; Nakase, H; RIZZUTO, ROSARIO ; Lombes, A; Shanske, S; Schon, E A	PROGRESS IN CLINICAL AND BIOLOGICAL RESEARCH
2	MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion	2006	Spinazzola A.; VISCOMI, CARLO FIORE ; Fernandez-Vizarra E.; Carrara F.; D'ADAMO, PIERVINCENZO ; Calvo S.; Marsano R. M.; Donnini C.; Weiher H.; Strisciuglio P.; Parini R.; Sarzi E.; Chan A.; DiMauro S.; Rotig A.; Gasparini P.; Ferrero I.; Mootha V. K.; Tiranti V.; ZEVIANI, MASSIMO	NATURE GENETICS
3	Lactic acidosis in a newborn with adrenal calcifications	2009	Zecic A.; Smet J. E.; De Praeter C. M.; Piet V.; VISCOMI, CARLO FIORE ; Van Den Broecke C.; De Paepe B.; Peter L.; Martin J. -J.; Jackson J. G.; Campbell C. R.; De Meirleir L. J.; ZEVIANI, MASSIMO ; Seneca S. H.; Willy L.; Van Coster R.	PEDIATRIC RESEARCH
4	Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy	2009	Tiranti V.; VISCOMI, CARLO FIORE ; Hildebrandt T.; Di Meo I.; Mineri R.; Tiveron C.; D Levitt M.; Prelle A.; Fagiolari G.; RIMOLDI, LORENZO MARCO ; ZEVIANI, MASSIMO	NATURE MEDICINE
5	Early-onset liver mtDNA depletion and late-onset proteinuric nephropathy in Mpv17 knockout mice	2009	VISCOMI, CARLO FIORE ; Spinazzola A.; MAGGIONI, MARIA LUISA ; Fernandez-Vizarra E.; Massa V.; PAGANO, CLAUDIO ; VETTOR, ROBERTO ; MORA, MARCO ; ZEVIANI, MASSIMO	HUMAN MOLECULAR GENETICS
6	Paroxysmal non-kinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence	2009	GHEZZI, DANIELE ; VISCOMI, CARLO FIORE ; Ferlini A.; Gualandi F.; Mereghetti P.; Degrandis D.; ZEVIANI, MASSIMO	HUMAN MOLECULAR GENETICS
7	Localized cerebral energy failure in DNA polymerase gamma-associated encephalopathy syndromes	2010	Tzoulis C.; Neckelmann G.; Mork S. J.; Engelsen B. E.; VISCOMI, CARLO FIORE ; Moen G.; Ersland L.; ZEVIANI, MASSIMO ; Bindoff L. A.	BRAIN
8	Combined treatment with oral metronidazole and N-acetylcysteine is effective in ethylmalonic encephalopathy	2010	VISCOMI, CARLO FIORE ; Burlina A. B.; Dweikat I.; Savoiardo M.; Lamperti C.; Hildebrandt T.; Tiranti V.; ZEVIANI, MASSIMO	NATURE MEDICINE
9	Evolution meets disease: Penetrance and functional epistasis of mitochondrial tRNA mutations	2011	Moreno-Loshuertos R.; Ferrin G.; Acin-Perez R.; Gallardo M. E.; VISCOMI, CARLO FIORE ; Perez-Martos A.; ZEVIANI, MASSIMO ; Fernandez-Silva P.; Enriquez J. A.	PLOS GENETICS
10	In vivo correction of COX deficiency by activation of the AMPK/PGC-1α axis	2011	VISCOMI, CARLO FIORE ; Bottani E.; Civiletto G.; Cerutti R.; Moggio M.; Fagiolari G.; Schon E. A.; Lamperti C.; ZEVIANI, MASSIMO	CELL METABOLISM
11	Hypoxic and hypercapnic challenges unveil respiratory vulnerability of Surf1 knockout mice, an animal model of Leigh syndrome	2011	Stettner G. M.; VISCOMI, CARLO FIORE ; ZEVIANI, MASSIMO ; Wilichowski E.; Dutschmann M.	MITOCHONDRION
12	Chronic exposure to sulfide causes accelerated degradation of cytochrome c oxidase in ethylmalonic encephalopathy	2011	Di Meo I.; Fagiolari G.; Prelle A.; VISCOMI, CARLO FIORE ; ZEVIANI, MASSIMO ; Tiranti V.	ANTIOXIDANTS & REDOX SIGNALING
13	Effective AAV-mediated gene therapy in a mouse model of ethylmalonic encephalopathy	2012	Di Meo I.; Auricchio A.; Lamperti C.; BURLINA, ALBERTO ; VISCOMI, CARLO FIORE ; ZEVIANI, MASSIMO	EMBO MOLECULAR MEDICINE
14	Morphologic evidence of diffuse vascular damage in human and in the experimental model of ethylmalonic encephalopathy	2012	Giordano C.; VISCOMI, CARLO FIORE ; Orlandi M.; Papoff P.; Spalice A.; BURLINA, ALBERTO ; Di Meo I.; Tiranti V.; Leuzzi V.; D'AMATI, GIULIA ; ZEVIANI, MASSIMO	JOURNAL OF INHERITED METABOLIC DISEASE
15	Proteome adaptations in Ethe1-deficient mice indicate a role in lipid catabolism and cytoskeleton organization via post-translational protein modifications	2013	Hildebrandt T. M.; Di Meo I.; ZEVIANI, MASSIMO ; VISCOMI, CARLO FIORE ; Braun H. -P.	BIOSCIENCE REPORTS
16	Decreased in vitro mitochondrial function is associated with enhanced brain metabolism, blood flow, and memory in Surf1-deficient mice	2013	Lin A. -L.; Pulliam D. A.; Deepa S. S.; Halloran J. J.; Hussong S. A.; Burbank R. R.; Bresnen A.; Liu Y.; Podlutskaya N.; Soundararajan A.; Muir E.; Duong T. Q.; Bokov A. F.; VISCOMI, CARLO FIORE ; ZEVIANI, MASSIMO ; Richardson A. G.; Van Remmen H.; Fox P. T.; Galvan V.	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
17	Pharmacological inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle	2014	Pirinen E.; Canto C.; Jo Y. S.; Morato L.; Zhang H.; Menzies K. J.; Williams E. G.; Mouchiroud L.; Moullan N.; Hagberg C.; Li W.; Timmers S.; Imhof R.; Verbeek J.; Pujol A.; Van Loon B.; VISCOMI, CARLO FIORE ; ZEVIANI, MASSIMO ; Schrauwen P.; Sauve A. A.; Schoonjans K.; Auwerx J.	CELL METABOLISM
18	Gene therapy using a liver-targeted AAV vector restores nucleoside and nucleotide homeostasis in a murine model of MNGIE	2014	Torres-Torronteras J.; VISCOMI, CARLO FIORE ; Cabrera-Perez R.; Camara Y.; Di Meo I.; Barquinero J.; Auricchio A.; Pizzorno G.; Hirano M.; ZEVIANI, MASSIMO ; Marti R.	MOLECULAR THERAPY
19	NAD+-dependent activation of Sirt1 corrects the phenotype in a mouse model of mitochondrial disease	2014	Cerutti R.; Pirinen E.; Lamperti C.; Marchet S.; Sauve A. A.; Li W.; Leoni V.; Schon E. A.; Dantzer F.; Auwerx J.; VISCOMI, CARLO FIORE ; ZEVIANI, MASSIMO	CELL METABOLISM
20	AAV-mediated liver-specific MPV17 expression restores mtdna levels and prevents diet-induced liver failure	2014	Bottani E.; Giordano C.; Civiletto G.; Di Meo I.; Auricchio A.; Ciusani E.; Marchet S.; Lamperti C.; D'Amati G.; VISCOMI, CARLO FIORE ; ZEVIANI, MASSIMO	MOLECULAR THERAPY

Dettaglio

Nome completo

ZEVIANI, MASSIMO

Afferenza

Dipartimento di Neuroscienze - DNS